Basel, Switzerland

Juerg Hunziker


 

 

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 72(Granted Patents)


Location History:

  • Aarau, CH (2013 - 2017)
  • Basel, CH (2011 - 2021)

Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Juerg Hunziker: Innovator in RNA Interference

Introduction

Juerg Hunziker, a prominent inventor based in Basel, Switzerland, has made significant contributions to the field of molecular biology and pharmacology. With a total of 12 patents to his name, he has focused on developing innovative solutions for RNA interference (RNAi) technologies and treatments for viral infections. His inventive spirit and dedication to scientific advancement have positioned him as a notable figure in the industry.

Latest Patents

Hunziker's most recent patents include groundbreaking research on 3' end caps for RNAi agents, specifically designed for use in RNA interference. This invention revolves around novel compounds and compositions comprising an RNAi agent with a unique 3' end cap, along with methodologies for crafting these compositions. Additionally, he has contributed to the field with organic compounds aimed at treating hepatitis B virus (HBV). This patent highlights innovative compositions that integrate a HBV RNAi agent featuring sense and anti-sense strands in a structured duplex formation, alongside advanced methodologies for synthesizing and applying these compositions therapeutically.

Career Highlights

Throughout his career, Juerg Hunziker has worked with renowned companies such as Novartis AG and Seqirus UK Limited. His collaborative efforts in these prestigious organizations have facilitated the advancement of biotechnology and therapeutic solutions, allowing the integration of his inventive ideas into practical applications that have the potential to improve patient outcomes.

Collaborations

Hunziker has had the opportunity to collaborate with esteemed colleagues, including Francois Jean-Charles Natt and Eric Billy. These partnerships have enriched his work and expanded the scope of his innovations, leading to a more profound impact on the scientific community and the development of effective therapies.

Conclusion

In summary, Juerg Hunziker stands out as a vital contributor to the innovation of RNAi technologies and therapeutic treatments for viral diseases. With a rich history of patents and collaborations, he continues to push the boundaries of science and medicine, paving the way for future advancements in the field. His work exemplifies the crucial role inventors play in enhancing healthcare through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…